SynthesisClinical and experimental medicine2025
Predictive and prognostic value of the neutrophil-to-lymphocyte ratio for acute kidney injury: a systematic review and meta-analysis.
Synthesis in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Advanced lung cancer inflammation index is associated with mortality in critically ill patients with acute kidney injury.Clinics (Sao Paulo, Brazil) · 2026Article
- Glucose-to-potassium ratio has a non-linear J-shaped association with acute kidney injury risk in traumatic brain injury.Scientific reports · 2026Article
- Inflammation and hypoalbuminemia mediate the association between CKD and contrast-associated AKI.European journal of medical research · 2026Article
- Machine Learning-Based Prediction and Feature Attribution Analysis of Contrast-Associated Acute Kidney Injury in Patients with Acute Myocardial Infarction.Medicina (Kaunas, Lithuania) · 2026Article
- Prognostic Value of the Neutrophil-to-Lymphocyte Ratio for All-Cause Mortality in Patients With Cardiovascular-Kidney-Metabolic Stage 4.Mediators of inflammation · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The neutrophil-to-lymphocyte ratio (NLR) has been suggested as a potential biomarker for the prediction and risk stratification of acute kidney injury (AKI), but conflicting results were reported by literature. We therefore conducted a pooled analysis to consolidate available evidence regarding the predictive and prognostic value of NLR in AKI patients. A systematic search was performed in the PubMed/Medline, Embase, and Cochrane Central Register of Controlled Trials (Central) databases from inception to March 2025 for cohort studies investigating the association between NLR and AKI. Quality assessment was performed via the Quality Assessment for Studies of Diagnostic Accuracy (QUADAS-2) tool. The predictive and prognostic value of the NLR for AKI was evaluated via pooled estimates of odds ratio (OR), sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NeLR), diagnostic score (DS), diagnostic odds ratio (DOR), summary receiver operating characteristic (SROC) curves, and the Fagan nomogram. Twenty-nine studies with 102,870 patients were pooled in this meta-analysis. Higher NLR was associated an increased risk of AKI (OR 1.52, 95% CI 1.29-1.79; p < 0.001). The pooled sensitivity and specificity were 0.70 (95% CI 0.65-0.74) and 0.67 (95% CI 0.60-0.74). The combined values of the PLR, NeLR, DS, and DOR were 2.13 (1.74-2.60), 0.45 (0.38-0.52), 1.56 (1.24-1.89), and 4.78 (3.46-6.60), respectively, with a pooled area under the curve (AUC) for the SROC being 0.74 (95% CI 0.70-0.78). Subgroup analysis suggested that the associations remained statistically significant in contrast-associated AKI (p < 0.001) and surgery-associated AKI (p < 0.001), but of boarder line significance in sepsis-associated AKI (p = 0.082). In addition, higher NLR was also found to be related to 1.47-fold increase in mortality among AKI patients (OR 1.47, 95% CI 1.13-1.91, p = 0.004). NLR is not only an effective marker for predicting AKI event, but also a prognostic tool to identify AKI patients with higher risk of death. Future studies are needed to justify its value in different AKI subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.